Advertisement

Tens of thousands in Hong Kong to have their DNA sequenced in government-backed genome project

  • People with undiagnosed genetic disorders and cancers to be among first batch of cases
  • Researchers aim to build database that can boost diagnoses of rare illnesses and aid bespoke cancer treatments

Reading Time:2 minutes
Why you can trust SCMP
Whole genome sequencing reveals a person’s complete DNA. Photo: Shutterstock

Tens of thousands of Hongkongers will have their entire genetic code decrypted in a government-backed project aimed at building a database to boost diagnoses of rare illnesses and aid bespoke cancer treatments.

Advertisement

Whole genome sequencing, a process which reveals all the information stored in a person’s DNA, will be performed on the targeted group, which will include people with uncommon genetic disorders and cancers.

In a document on the Hong Kong Genome Project, which the Food and Health Bureau handed to the Legislative Council on Tuesday for discussion next Monday, the bureau revealed that the project would cover 20,000 cases. As two or more samples might be collected in a case, such as collecting data from a patient and their parents for an undiagnosed genetic disorder, it was estimated the project would sequence 40,000 to 50,000 genomes.

According to the plan, the project – first announced by Chief Executive Carrie Lam Cheng Yuet-ngor in her policy address last year – will be conducted in two phases. The pilot phase will first cover 2,000 cases of undiagnosed disorders and cancers which are possibly linked to hereditary genetic components. The main phase will look into 18,000 cases, including diseases covered in the pilot phase and other diseases that would benefit from whole genome sequencing.

Researchers will be able to access the anonymised data for studies including those related to cancer and how genes affect a person’s response to drugs. That information, it is hoped, will help in diagnosing uncommon disorders and developing more personalised treatment for cancer patients.

Advertisement
loading
Advertisement